EBR systems earns Medicare win for leadless pacing tech
June 9, 2026
EBR Systems said today that a new Medicare National Coverage Determination (NCD) will evaluate its leadless endocardial pacing technology.
EBR Systems said today that a new Medicare National Coverage Determination (NCD) will evaluate its leadless endocardial pacing technology.
Mayo Clinic researchers and collaborators have shown that artificial intelligence (AI) can analyze routine pathology slides to help classify meningiomas, the most common primary brain tumor in adults, and predict a patient’s risk of tumor recurrence.
By inducing specific patterns of activity in small portions of the brain in awake mice, researchers have triggered a recalibration of neural connections that normally only occurs during sleep. This new approach offset the effects of sleep deprivation on memory tasks and revealed features of sleep that are key to its restorative effect.
An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of the biggest public health issues globally—bacterial infections.
Game directly treated impaired arm rather than teaching ways to compensate for lack of function
The regulatory clearance covers the t:slim X2 and Tandem Mobi insulin pumps with Control-IQ+ technology.
The automated system is now available in the US, offering faster bloodstream infection detection and higher vial-loading capacity for high-throughput microbiology laboratories.
The app-integrated tool automates left ventricular ejection fraction assessment, supporting real-time cardiac evaluation in primary care and emergency settings.
The procedure is comparable to hip and knee replacement surgeries, where a prosthetic implant is used to replace damaged joint surfaces
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent processor.